Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer

por Gao, Yina, Dong, Yangyang, Zhou, Yingxu, Chen, Gongyan, Hong, Xuan, Zhang, Qingyuan
Publicado 2022

CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells

por Wang, Meng, Lin, Tie, Wang, Yicun, Gao, Song, Yang, Zhaoyang, Hong, Xuan, Chen, Gongyan
Publicado 2017

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in...

por Chang, Jianhua, Chen, Gongyan, Wang, Dong, Wang, Guihua, Lu, Shun, Feng, Jifeng, Li, Wei, Li, Ping, Lanzarotti, Corinna, Chessari, Salvatore, Zhang, Li
Publicado 2020

Clinical Characteristics Correlate With Outcomes of Immunotherapy in Advanced Non-Small Cell Lung Cancer

por Huang, Lan, Li, Li, Zhou, Yingxu, Yang, Zhaoyang, Wang, Meng, Gao, Yina, Yang, Yang, Yang, Fang, Liu, Bao, Hong, Xuan, Chen, Gongyan
Publicado 2020

Anlotinib for patients with small cell lung cancer and baseline liver metastases: A post hoc analysis of the ALTER 1202 trial

por Cheng, Ying, Wang, Qiming, Li, Kai, Shi, Jianhua, Wu, Lin, Han, Baohui, Chen, Gongyan, He, Jianxing, Wang, Jie, Qin, Haifeng, Li, Xiaoling
Publicado 2021

Effectiveness of anlotinib in patients with small‐cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study

por Liu, Ying, Cheng, Ying, Wang, Qiming, Li, Kai, Shi, Jianhua, Wu, Lin, Han, Baohui, Chen, Gongyan, He, Jianxing, Wang, Jie, Qin, Haifeng, Li, Xiaoling
Publicado 2021

Camrelizumab Plus Apatinib in Treatment-Naive Patients With Advanced Nonsquamous NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 2 Trial

por Ren, Shengxiang, He, Jianxing, Fang, Yong, Chen, Gongyan, Ma, Zhiyong, Chen, Jianhua, Guo, Renhua, Lin, Xiaoyan, Yao, Yu, Wu, Gang, Wang, Quanren, Zhou, Caicun
Publicado 2022

Efficacy and safety of camrelizumab plus apatinib as second-line treatment for advanced squamous non-small cell lung cancer

por Gao, Guanghui, Zhao, Jun, Ren, Shengxiang, Wang, Yina, Chen, Gongyan, Chen, Jianhua, Gu, Kangsheng, Guo, Renhua, Pan, Yueyin, Wang, Quanren, Li, Weixia, Yang, Xinfeng, Zhou, Caicun
Publicado 2022

Effect of prior thoracic radiotherapy on prognosis in relapsed small cell lung cancer patients treated with anlotinib: a subgroup analysis of the ALTER 1202 trial

por Liu, Yang, Cheng, Ying, Li, Kai, Shi, Jianhua, Liu, Ying, Wu, Lin, Han, Baohui, Chen, Gongyan, He, Jianxing, Wang, Jie, Qin, Haifeng, Li, Xiaoling, Hamaji, Masatsugu, Park, Henry S.
Publicado 2021

Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE...

por Zhang, Li, Lu, Shun, Cheng, Ying, Hu, Zhihuang, Wu, Yi-Long, Chen, Zhiwei, Chen, Gongyan, Liu, Xiaoqing, Yang, Jinji, Zhang, Li, Chen, Jia, Huang, Meijuan, Tao, Min, Cheng, Gang, Huang, Cheng, Zhou, Caicun, Zhang, Weimin, Zhao, Hong, Sun, Yuping
Publicado 2021

Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1‐positive locally advanced or metastatic non–small‐cell lung cancer:...

por Wu, Yi‐Long, Zhang, Li, Fan, Yun, Zhou, JianYing, Zhang, Li, Zhou, Qing, Li, Wei, Hu, ChengPing, Chen, GongYan, Zhang, Xin, Zhou, CaiCun, Dang, Thao, Sadowski, Sara, Kush, Debra A., Zhou, Yu, Li, Ben, Mok, Tony
Publicado 2020

An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870)

por Lu, Shun, Cheng, Ying, Zhou, Jianying, Wang, Mengzhao, Zhao, Jun, Wang, Baocheng, Chen, Gongyan, Feng, Jifeng, Ma, Zhiyong, Wu, Lin, Wang, Changli, Ma, Kewei, Zhang, Shucai, Liang, Jun, Song, Yong, Wang, Jie, Wu, Yi-Long, Li, Ang, Huang, Yizhi, Chang, Jianhua
Publicado 2022

Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration

por Gao, Guanghui, Ni, Jian, Wang, Yina, Ren, Shengxiang, Liu, Zhihua, Chen, Gongyan, Gu, Kangsheng, Zang, Aimin, Zhao, Jun, Guo, Renhua, He, Jianxing, Lin, Xiaoyan, Pan, Yueyin, Ma, Zhiyong, Wang, Zhehai, Fan, Min, Liu, Yunpeng, Cang, Shundong, Yang, Xinfeng, Li, Weixia, Wang, Quanren, Zhou, Caicun
Publicado 2022

Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: 
Safety, Efficacy, and Biomarkers

por Wang, Yakun, Liu, Tianshu, Chen, Gongyan, Gong, Jifang, Bai, Yuxian, Zhang, Tao, Xu, Nong, Liu, Li, Xu, Jianming, He, Jianxing, Liu, Yunpeng, Zhang, Li, Jiang, Da, Wang, Mengzhao, Chang, Jianhua, Li, Wei, Bai, Chunmei, Zhou, Jinghong, Wang, Jian, Ren, Yongxin, Zhang, Liya, Su, Weiguo, Liu,, Baorui, Shen, Lin
Publicado 2022

Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations

por Lu, Shun, Fang, Jian, Li, Xingya, Cao, Lejie, Zhou, Jianying, Guo, Qisen, Liang, Zongan, Cheng, Ying, Jiang, Liyan, Yang, Nong, Han, Zhigang, Shi, Jianhua, Chen, Yuan, Xu, Hua, Zhang, Helong, Chen, Gongyan, Ma, Rui, Sun, Sanyuan, Fan, Yun, Fan, Songhua, Yu, Jie, Lu, Puhan, Luo, Xian, Su, Weiguo
Publicado 2022

Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phas...

por Yu, Yongfeng, Ren, Yongxin, Fang, Jian, Cao, Lejie, Liang, Zongan, Guo, Qisen, Han, Sen, Ji, Zimei, Wang, Ye, Sun, Yulan, Chen, Yuan, Li, Xingya, Xu, Hua, Zhou, Jianying, Jiang, Liyan, Cheng, Ying, Han, Zhigang, Shi, Jianhua, Chen, Gongyan, Ma, Rui, Fan, Yun, Sun, Sanyuan, Jiao, Longxian, Jia, Xiaoyun, Wang, Linfang, Lu, Puhan, Xu, Qian, Luo, Xian, Su, Weiguo, Lu, Shun
Publicado 2022

On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial

por Jiang, Tao, Chen, Jianhua, Xu, Xingxiang, Cheng, Ying, Chen, Gongyan, Pan, Yueyin, Fang, Yong, Wang, Qiming, Huang, Yunchao, Yao, Wenxiu, Wang, Rui, Li, Xingya, Zhang, Wei, Zhang, Yanjun, Hu, Sheng, Guo, Renhua, Shi, Jianhua, Wang, Zhiwu, Cao, Peiguo, Wang, Donglin, Fang, Jian, Luo, Hui, Geng, Yi, Xing, Chunyan, Lv, Dongqing, Zhang, Yiping, Yu, Junyan, Cang, Shundong, Zhang, Yaxi, Zhang, Jiao, Yang, Zeyu, Shi, Wei, Zou, Jianjun, Zhou, Caicun, Ren, Shengxiang
Publicado 2022

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade...

por Wu, Fengying, Jiang, Tao, Chen, Gongyan, Huang, Yunchao, Zhou, Jianying, Lin, Lizhu, Feng, Jifeng, Wang, Zhehai, Shu, Yongqian, Shi, Jianhua, Hu, Yi, Wang, Qiming, Cheng, Ying, Chen, Jianhua, Lin, Xiaoyan, Wang, Yongsheng, Huang, Jianan, Cui, Jiuwei, Cao, Lejie, Liu, Yunpeng, Zhang, Yiping, Pan, Yueyin, Zhao, Jun, Wang, LiPing, Chang, Jianhua, Chen, Qun, Ren, Xiubao, Zhang, Wei, Fan, Yun, He, Zhiyong, Fang, Jian, Gu, Kangsheng, Dong, Xiaorong, Zhang, Tao, Shi, Wei, Zou, Jianjun, Bai, Xuejuan, Ren, Shengxiang, Zhou, Caicun
Publicado 2022

Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Commi...

por Ba, Yi, Shi, Yuankai, Jiang, Wenqi, Feng, Jifeng, Cheng, Ying, Xiao, Li, Zhang, Qingyuan, Qiu, Wensheng, Xu, Binghe, Xu, Ruihua, Shen, Bo, Luo, Zhiguo, Xie, Xiaodong, Chang, Jianhua, Wang, Mengzhao, Li, Yufu, Shuang, Yuerong, Niu, Zuoxing, Liu, Bo, Zhang, Jun, Zhang, Li, Yao, Herui, Xie, Conghua, Huang, Huiqiang, Liao, Wangjun, Chen, Gongyan, Zhang, Xiaotian, An, Hanxiang, Deng, Yanhong, Gong, Ping, Xiong, Jianping, Yao, Qinghua, An, Xin, Chen, Cheng, Shi, Yanxia, Wang, Jialei, Wang, Xiaohua, Wang, Zhiqiang, Xing, Puyuan, Yang, Sheng, Zhou, Chenfei
Publicado 2020

Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcino...

por Zhang, Jie, Pan, Yueyin, Shi, Qin, Zhang, Guojun, Jiang, Liyan, Dong, Xiaorong, Gu, Kangsheng, Wang, Huijuan, Zhang, Xiaochun, Yang, Nong, Li, Yuping, Xiong, Jianping, Yi, Tienan, Peng, Min, Song, Yong, Fan, Yun, Cui, Jiuwei, Chen, Gongyan, Tan, Wei, Zang, Aimin, Guo, Qisen, Zhao, Guangqiang, Wang, Ziping, He, Jianxing, Yao, Wenxiu, Wu, Xiaohong, Chen, Kai, Hu, Xiaohua, Hu, Chunhong, Yue, Lu, Jiang, Da, Wang, Guangfa, Liu, Junfeng, Yu, Guohua, Li, Junling, Bai, Jianling, Xie, Wenmin, Zhao, Weihong, Wu, Lihong, Zhou, Caicun
Publicado 2021